Free shipping on all orders over $ 500

NNZ-2591

Cat. No. M25421

All AbMole products are for research use only, cannot be used for human consumption.

NNZ-2591 Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

Quality Control & Documentation
Biological Activity

NNZ-2591 is a synthetic analogue of a small peptide of cyclic glycine proline (cGP). NNZ-2591 shows orally active and cross the blood-brain barrier. NNZ-2591 shows neuroprotective after ischemic brain injury.

NNZ-2591 (30 mg/kg; p.o.) prevented scopolamine-induced memory impairment in rats. NNZ-2591 (3 mg/kg; s.c.; daily for 5 days) completely preventes brain damage and significantly reduces the L/R ratio of time taken to touch to the patch at 5 d after injury in rats.

NNZ-2591 has the potential for the research of ischemic brain injury and angelman syndrome.

Chemical Information
Molecular Weight 194.23
Formula C10H14N2O2
CAS Number 847952-38-9
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Jian Guan, et al. Recent Pat CNS Drug Discov. Insulin-like growth factor-1 and its derivatives: potential pharmaceutical application for treating neurological conditions

[2] Jian Guan, et al. Behav Brain Res. NNZ-2591, a novel diketopiperazine, prevented scopolamine-induced acute memory impairment in the adult rat

[3] Jian Guan, et al. Br J Pharmacol. IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions

[4] R V M Krishnamurthi, et al. Br J Pharmacol. A novel diketopiperazine improves functional recovery given after the onset of 6-OHDA-induced motor deficit in rats

[5] J Guan, et al. Neuropharmacology. Peripheral administration of a novel diketopiperazine, NNZ 2591, prevents brain injury and improves somatosensory-motor function following hypoxia-ischemia in adult rats

Related Peptides Products
Amylin amide, human TFA

Amylin amide, human TFA is a 37-amino acid polypeptide, it is a pancreatic hormone cosecreted with insulin that exerts unique roles in metabolism and glucose homeostasis. Amylin amide, human TFA inhibits glucagon secretion, delays gastric emptying.
WL47 TFA

WL47 TFA, a high-affinity cavolin-1 (CAV1) ligand (Kd=23 nM), is a potent disrupter of CAV1 oligomers. WL47 TFA shows selectivity for CAV1 over BSA, casein and HEWL. WL47 TFA can be used for the study of caveolin-1 function.
Angiopep-2-Cys TFA

Angiopep-2-cys is a conjugate of Angiopep-2 hydrochloride and cysteine. The conjugation of anticancer agents with the Angiopep-2 peptide vector could increase their efficacy in the treatment of brain cancer.
H3K4(Me2) (1-20)

H3K4(Me2) (1-20) is a histone peptide. H3K4me2 regulates the recovery of protein biosynthesis and homeostasis following DNA damage.
Elcatonin

Elcatonin is a synthetic analog of eel calcitonin that increases bone density and inhibits bone resorption.
  Catalog
Abmole Inhibitor Catalog




Keywords: NNZ-2591 supplier, Peptides, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.


 
Get to Know Us
Customer Support
Resources
Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.